Cranberry extract initiates intrinsic apoptosis in HL-60 cells by increasing BAD activity through inhibition of AKT phosphorylation

BMC Complementary Medicine and Therapies
Rasha A Mansouri, Susan S Percival

Abstract

Cranberry has been studied as a potential anticancer agent as it is capable of inducing apoptosis within cancer cells. The aim of this study was to better define the mechanism by which cranberry triggers apoptosis in HL-60 cells. The study was carried on cranberry extracts (CB). Anti-apoptotic B-cell lymphoma-2 (BCL-2) and pro-apoptotic BCL-2-associated death promoter death (BAD) proteins in cell lysates were detected through Western blotting techniques. Equivalent protein loading was confirmed through anti-α-tubulin antibody. The results showed that treatment of HL-60 cells with CB causes a significant increase in the levels of caspase-9 and caspases-3/7 and increased mitochondrial outer membrane permeability, leading to the release of cytochrome C and Smac. These apoptotic events were associated with a significant decrease in protein kinase B (AKT) phosphorylation, which caused significant increase in BAD de-phosphorylation and promoted a sequence of events that led to intrinsic apoptosis. The study findings have described a molecular framework for CB-initiated apoptosis in HL-60 cells and suggested a direction for future in vivo studies investigating the anticancer effect of cranberry.

References

May 23, 2001·Leukemia·P P RuvoloW S May
Feb 28, 2004·The Journal of Nutrition·Liwei GuRonald L Prior
Jul 27, 2004·Protein Science : a Publication of the Protein Society·Yigong Shi
Sep 29, 2004·The Biochemical Journal·Pablo Fuentes-Prior, Guy S Salvesen
Nov 3, 2004·Nature Reviews. Molecular Cell Biology·Stefan J Riedl, Yigong Shi
Feb 3, 2007·Cell Death and Differentiation·A U Lüthi, S J Martin
Jun 15, 2007·Toxicologic Pathology·Susan Elmore
May 23, 2008·Cytokine & Growth Factor Reviews·Avi Ashkenazi
Aug 5, 2010·Nature Reviews. Molecular Cell Biology·Stephen W G Tait, Douglas R Green
Mar 15, 2011·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Laura A KrestyMaureen Baird
Sep 17, 2011·International Journal of Oncology·Kyu Kwang KimRichard G Moore
Nov 10, 2013·Cell Death & Disease·M Kvansakul, M G Hinds
Mar 10, 2015·Molecular Cancer·Zhenyi SuQiang Yu
Dec 15, 2015·Nature Reviews. Immunology·Si Ming Man, Thirumala-Devi Kanneganti
Dec 20, 2015·Immunological Reviews·Kristen K Penberthy, Kodi S Ravichandran
Jan 15, 2018·Methods in Molecular Biology·Dong XiaoLong-Fei He
Jun 28, 2018·Cell Proliferation·Gelina S KopeinaBoris Zhivotovsky

❮ Previous
Next ❯

Methods Mentioned

BETA
ELISA
Protein Assay

Software Mentioned

AlphaView
SigmaPlot
Apo
ONE®

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptotic Caspases

Apoptotic caspases belong to the protease enzyme family and are known to play an essential role in inflammation and programmed cell death. Here is the latest research.

Related Papers

The Australian Nursing Journal : ANJ
Sheryl Pretty, Kay McCauley
Anti-cancer Agents in Medicinal Chemistry
Maria MantzorouConstantinos Giaginis
Voprosy pitaniia
I F BorukhG V Senchuk
Journal of Wound, Ostomy, and Continence Nursing : Official Publication of the Wound, Ostomy and Continence Nurses Society
Mikel Gray
© 2021 Meta ULC. All rights reserved